BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 556692)

  • 21. Plasma malondialdehyde levels and opiate withdrawal signs observed in rats treated with morphine plus naloxone: effects of alpha-lipoic acid administration.
    Pinelli A; Cighetti G; Trivulzio S
    Fundam Clin Pharmacol; 2008 Aug; 22(4):439-45. PubMed ID: 18705754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in sensitivity to apomorphine during morphine dependence and withdrawal in rats.
    Cox B; Ary M; Lomax P
    J Pharmacol Exp Ther; 1976 Mar; 196(3):637-41. PubMed ID: 944260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of D-phenylalanine and its derivatives on enkephalin degradation in vitro: relation to analgesia and attenuation of the morphine withdrawal syndrome.
    Janicki PK; Gumułka SW; Szreniawski Z; Paulo EA; Arnold Z
    Pol J Pharmacol Pharm; 1986; 38(1):41-9. PubMed ID: 3763485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitation of physical dependence in mice by naloxone-precipitated jumping after a single dose of morphine.
    Smits SE
    Res Commun Chem Pathol Pharmacol; 1975 Apr; 10(4):651-61. PubMed ID: 1171511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Action of enkephalin analogues and morphine on brain acetylcholine release: differential reversal by naloxone and an opiate pentapeptide.
    Jhamandas K; Sutak M
    Br J Pharmacol; 1980; 71(1):201-10. PubMed ID: 7470736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of abstinence syndrome in opiate dependent mice by cyclo (His-Pro).
    Bhargava HN
    Life Sci; 1981 Mar; 28(11):1261-7. PubMed ID: 7194956
    [No Abstract]   [Full Text] [Related]  

  • 27. Suppression of naloxone-precipitated withdrawal jumps in morphine-dependent mice by stimulation of prostaglandin EP3 receptor.
    Nakagawa T; Minami M; Katsumata S; Ienaga Y; Satoh M
    Br J Pharmacol; 1995 Nov; 116(6):2661-6. PubMed ID: 8590986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Physical dependence of opiate-like peptides.
    Wei E; Loh H
    Science; 1976 Sep; 193(4259):1262-3. PubMed ID: 986687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phenylmethanesulfonyl fluoride, a serine protease inhibitor, suppresses naloxone-precipitated withdrawal jumping in morphine-dependent mice.
    Nemoto W; Sato T; Nakagawasai O; Yaoita F; Silberring J; Tadano T; Tan-No K
    Neuropeptides; 2013 Jun; 47(3):187-91. PubMed ID: 23290539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Precipitation and prevention of abstinence in acutely morphinized rats and mice: comparisons between naloxone, naltrexone, and diprenorphine (author's transl)].
    Tremblay E; Colombel MC; Jacob J
    Psychopharmacology (Berl); 1976 Aug; 49(1):41-8. PubMed ID: 822446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. beta-Lactam antibiotic inhibits development of morphine physical dependence in rats.
    Rawls SM; Baron DA; Kim J
    Behav Pharmacol; 2010 Mar; 21(2):161-4. PubMed ID: 20215965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clonidine and naloxone-induced opiate withdrawal: a comparison between clonidine and morphine in man.
    Fantozzi R; Luciani G; Masini E; Blandina P; Mannaioni P
    Subst Alcohol Actions Misuse; 1980; 1(4):369-73. PubMed ID: 7302789
    [No Abstract]   [Full Text] [Related]  

  • 33. Potential involvement of tyrosine phosphatase and calpain-related pathways in opioid withdrawal syndrome in mice.
    Rehni AK; Singh N
    Behav Pharmacol; 2012 Jun; 23(3):302-9. PubMed ID: 22495184
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The differential profiles of withdrawal symptoms induced by morphine and beta-endorphin administered intracerebroventricularly in mice.
    Park SH; Sim YB; Kang YJ; Kim CH; Kwon MS; Suh HW
    Neuroscience; 2012 Aug; 218():216-25. PubMed ID: 22626645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of pargyline on morphine tolerance and physical dependence development in mice.
    Iwamoto ET; Ho IK; Way EL
    Eur J Pharmacol; 1976 Aug; 38(2):261-8. PubMed ID: 986307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of intracellular calcium on the modulation of naloxone-precipitated withdrawal jumping in morphine-dependent mice by diabetes.
    Ohsawa M; Kamei J
    Brain Res; 1999 Jan; 815(2):424-30. PubMed ID: 9878862
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intraventricular Met5-enkephalin causes unexpected lowering of pain threshold and narcotic withdrawal signs in rats.
    Leybin L; Pinsky C; LaBella FS; Havlicek V; Rezek M
    Nature; 1976 Dec; 264(5585):458-9. PubMed ID: 187953
    [No Abstract]   [Full Text] [Related]  

  • 38. Contractile effect of morphine and related opioid alkaloids, beta-endorphin and methionine enkephalin on the isolated colon from Long Evans rats.
    Huidobro-Toro JP; Way EL
    Br J Pharmacol; 1981 Nov; 74(3):681-94. PubMed ID: 6170377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of sodium cromoglycate on analgesia, locomotor activity and opiate withdrawal in mice.
    Leza JC; Lizasoain I; Martín-Clark OS; Lorenzo P
    Psychopharmacology (Berl); 1992; 107(4):595-600. PubMed ID: 1376478
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Involvement of delta 2 opioid receptors in the development of morphine dependence in mice.
    Miyamoto Y; Portoghese PS; Takemori AE
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1141-5. PubMed ID: 8383738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.